Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Gastrointestinal Stromal Tumors (GISTs) Treatment market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Gastrointestinal Stromal Tumors (GISTs) Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Gastrointestinal Stromal Tumors (GISTs) Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novartis
Boston Biomedical
AB Science
Natco Pharma
Arog Pharmaceuticals
Roche
Sun Pharmaceutical
Bayer
Immunicum
Pfizer
By Type:
Surgery
Targeted Therapy
Radiation Therapy
Chemotherapy
Ablation
Embolization
Others
By End-User:
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastrointestinal Stromal Tumors (GISTs) Treatment Market
-
1.3 Market Segment by Type
-
1.3.1 USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Surgery from 2016 to 2027
-
1.3.2 USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Targeted Therapy from 2016 to 2027
-
1.3.3 USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Radiation Therapy from 2016 to 2027
-
1.3.4 USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Chemotherapy from 2016 to 2027
-
1.3.5 USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Ablation from 2016 to 2027
-
1.3.6 USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Embolization from 2016 to 2027
-
1.3.7 USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
1.4.4 USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Gastrointestinal Stromal Tumors (GISTs) Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Gastrointestinal Stromal Tumors (GISTs) Treatment by Major Types
-
3.4.1 Market Size and Growth Rate of Surgery
-
3.4.2 Market Size and Growth Rate of Targeted Therapy
-
3.4.3 Market Size and Growth Rate of Radiation Therapy
-
3.4.4 Market Size and Growth Rate of Chemotherapy
-
3.4.5 Market Size and Growth Rate of Ablation
-
3.4.6 Market Size and Growth Rate of Embolization
-
3.4.7 Market Size and Growth Rate of Others
4 Segmentation of Gastrointestinal Stromal Tumors (GISTs) Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Gastrointestinal Stromal Tumors (GISTs) Treatment by Major End-Users
-
4.4.1 Market Size and Growth Rate of Gastrointestinal Stromal Tumors (GISTs) Treatment in Hospitals
-
4.4.2 Market Size and Growth Rate of Gastrointestinal Stromal Tumors (GISTs) Treatment in Clinics
-
4.4.3 Market Size and Growth Rate of Gastrointestinal Stromal Tumors (GISTs) Treatment in Ambulatory Surgical Centers
-
4.4.4 Market Size and Growth Rate of Gastrointestinal Stromal Tumors (GISTs) Treatment in Others
5 Market Analysis by Regions
-
5.1 USA Gastrointestinal Stromal Tumors (GISTs) Treatment Production Analysis by Regions
-
5.2 USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Landscape Analysis
-
6.1 West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Landscape Analysis by Major Types
-
6.2 West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Landscape Analysis by Major End-Users
7 South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Landscape Analysis
-
7.1 South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Landscape Analysis by Major Types
-
7.2 South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Landscape Analysis by Major End-Users
8 Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Landscape Analysis
-
8.1 Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Landscape Analysis by Major Types
-
8.2 Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Landscape Analysis by Major End-Users
9 Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Landscape Analysis
-
9.1 Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Landscape Analysis by Major Types
-
9.2 Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Novartis
-
10.1.1 Novartis Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Boston Biomedical
-
10.2.1 Boston Biomedical Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 AB Science
-
10.3.1 AB Science Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Natco Pharma
-
10.4.1 Natco Pharma Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Arog Pharmaceuticals
-
10.5.1 Arog Pharmaceuticals Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Roche
-
10.6.1 Roche Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Sun Pharmaceutical
-
10.7.1 Sun Pharmaceutical Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Bayer
-
10.8.1 Bayer Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Immunicum
-
10.9.1 Immunicum Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Pfizer
-
10.10.1 Pfizer Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Surgery from 2016 to 2027
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Targeted Therapy from 2016 to 2027
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Radiation Therapy from 2016 to 2027
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Chemotherapy from 2016 to 2027
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Ablation from 2016 to 2027
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Embolization from 2016 to 2027
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Gastrointestinal Stromal Tumors (GISTs) Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Gastrointestinal Stromal Tumors (GISTs) Treatment
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Gastrointestinal Stromal Tumors (GISTs) Treatment by Different Types from 2016 to 2027
-
Table Consumption Share of Gastrointestinal Stromal Tumors (GISTs) Treatment by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Surgery
-
Figure Market Size and Growth Rate of Targeted Therapy
-
Figure Market Size and Growth Rate of Radiation Therapy
-
Figure Market Size and Growth Rate of Chemotherapy
-
Figure Market Size and Growth Rate of Ablation
-
Figure Market Size and Growth Rate of Embolization
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Gastrointestinal Stromal Tumors (GISTs) Treatment by Different End-Users from 2016 to 2027
-
Table Consumption Share of Gastrointestinal Stromal Tumors (GISTs) Treatment by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Ambulatory Surgical Centers
-
Figure Market Size and Growth Rate of Others
-
Table USA Gastrointestinal Stromal Tumors (GISTs) Treatment Production by Regions
-
Table USA Gastrointestinal Stromal Tumors (GISTs) Treatment Production Share by Regions
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Production Share by Regions in 2016
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Production Share by Regions in 2021
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Production Share by Regions in 2027
-
Table USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption by Regions
-
Table USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Regions
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Regions in 2016
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Regions in 2021
-
Figure USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Regions in 2027
-
Table West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption by Types from 2016 to 2027
-
Table West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types from 2016 to 2027
-
Figure West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types in 2016
-
Figure West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types in 2021
-
Figure West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types in 2027
-
Table West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption by End-Users from 2016 to 2027
-
Table West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users in 2016
-
Figure West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users in 2021
-
Figure West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users in 2027
-
Table South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption by Types from 2016 to 2027
-
Table South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types from 2016 to 2027
-
Figure South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types in 2016
-
Figure South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types in 2021
-
Figure South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types in 2027
-
Table South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption by End-Users from 2016 to 2027
-
Table South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users in 2016
-
Figure South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users in 2021
-
Figure South USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users in 2027
-
Table Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption by Types from 2016 to 2027
-
Table Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types in 2016
-
Figure Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types in 2021
-
Figure Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types in 2027
-
Table Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users in 2016
-
Figure Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users in 2021
-
Figure Middle West USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users in 2027
-
Table Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption by Types from 2016 to 2027
-
Table Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types in 2016
-
Figure Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types in 2021
-
Figure Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by Types in 2027
-
Table Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users in 2016
-
Figure Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users in 2021
-
Figure Northeast USA Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Boston Biomedical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boston Biomedical
-
Figure Sales and Growth Rate Analysis of Boston Biomedical
-
Figure Revenue and Market Share Analysis of Boston Biomedical
-
Table Product and Service Introduction of Boston Biomedical
-
Table Company Profile and Development Status of AB Science
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AB Science
-
Figure Sales and Growth Rate Analysis of AB Science
-
Figure Revenue and Market Share Analysis of AB Science
-
Table Product and Service Introduction of AB Science
-
Table Company Profile and Development Status of Natco Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Natco Pharma
-
Figure Sales and Growth Rate Analysis of Natco Pharma
-
Figure Revenue and Market Share Analysis of Natco Pharma
-
Table Product and Service Introduction of Natco Pharma
-
Table Company Profile and Development Status of Arog Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arog Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Arog Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Arog Pharmaceuticals
-
Table Product and Service Introduction of Arog Pharmaceuticals
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Sun Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Sun Pharmaceutical
-
Figure Revenue and Market Share Analysis of Sun Pharmaceutical
-
Table Product and Service Introduction of Sun Pharmaceutical
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Immunicum
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunicum
-
Figure Sales and Growth Rate Analysis of Immunicum
-
Figure Revenue and Market Share Analysis of Immunicum
-
Table Product and Service Introduction of Immunicum
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
